Overview A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome Status: Completed Trial end date: 2007-09-01 Target enrollment: Participant gender: Summary Investigation of efficacy and safety of treatment with milnacipran in the treatment of fibromyalgia syndrome. Phase: Phase 3 Details Lead Sponsor: Pierre Fabre MedicamentTreatments: LevomilnacipranMilnacipran